Transaction in Own Shares

Centrica PLC
20 June 2023
 

 

Transactions in own shares

 

 

Centrica plc

20 June 2023

 

 

Centrica plc announces that today it purchased (through Merrill Lynch International) 3,283,052 Centrica plc ordinary shares of 6 14/81 pence each at a price of 119.9173 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme announced on 5 April 2023 and effected in accordance with the non-discretionary agreement entered into with Merrill Lynch International, as announced on 5 April 2023.

 

Since 5 April 2023, Centrica has purchased 98,287,228 ordinary shares at a cost (excluding dealing and associated costs) of £113,263,714.28.

 

Following the above purchase, Centrica plc holds 287,336,215 ordinary shares in treasury, and has 5,620,509,923 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Merrill Lynch International

Intermediary Code:

MLILGB3LESF

Currency:

GBP

Aggregated information

Date of purchase:

20 June 2023

Number of ordinary shares purchased:

3,283,052

Highest price paid:

120.5000p

Lowest price paid:

118.3500p

Volume weighted average price paid per share:

119.9173p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.


 http://www.rns-pdf.londonstockexchange.com/rns/3540D_1-2023-6-20.pdf

 

 

END

 

Enquiries:

Investors and Analysts
T: 01753 494900
E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Centrica (CNA)
UK 100

Latest directors dealings